I'm delaying hitting the sack until I see what MRK's numbers look like. They are due out within the hour.
Unlike PFE, MRK is a winner.
nope. mrk sucks. game over there. that stock is going down. what a POS company. clark is crazy to say they are positive and things look great. Give him new glasses.
MRK had a greater fall in percentage terms than Pfizer from both its pre-crash high and its bubble-economy high.Earlier in the decade, MRK suffered five consecutive years without a single year of earnings growth:$3.14 in 2001$3.14 in 2002$2.92 in 2003$2.61 in 2004$2.53 in 2005$2.52 in 2006Pfizer has never had more than a single down year.MRK has also had two incredible fiascoes the last lustrum or so:1) Vioxx2) Delaying for two years the adverse clinical tests for Vytorin and ZetiaMRK is also a lot more vulnerable than Pfizer is if government starts immediately taxing the earnings of foreign subsidiaries. PFE already pays a 30% tax while MRK's tax rate is just 25%.If they both had to pay 35% or close to it, MRK's earnings would be hit much harder.